Fox Run Management’s Globus Medical GMED Stock Holding History

Fox Run Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304K	Buy	3,842 +1,294	+51%	+$110K	0.05%	669
2026 Q1	$213K	Buy	+2,548	New	+$229K	0.04%	747
2024 Q2	–	Sell	-19,957	Closed	-$1.07M	–	879
2024 Q1	$1.07M	Buy	+19,957	New	+$1.07M	0.23%	109
2023 Q2	–	Sell	-12,973	Closed	-$735K	–	786
2023 Q1	$735K	Buy	+12,973	New	+$832K	0.24%	125
2021 Q4	–	Sell	-3,974	Closed	-$304K	–	560
2021 Q3	$304K	Buy	+3,974	New	+$319K	0.19%	222
2021 Q1	–	Sell	-6,413	Closed	-$418K	–	253
2020 Q4	$418K	Buy	+6,413	New	+$369K	0.84%	16
2020 Q1	–	Sell	-5,407	Closed	-$318K	–	217
2019 Q4	$318K	Buy	5,407 +1,341	+33%	+$72.8K	0.26%	170
2019 Q3	$208K	Buy	+4,066	New	+$194K	0.19%	295
2019 Q1	–	Sell	-12,099	Closed	-$524K	–	553
2018 Q4	$524K	Buy	+12,099	New	+$604K	0.28%	95
2018 Q2	–	Sell	-8,738	Closed	-$435K	–	761
2018 Q1	$435K	Buy	+8,738	New	+$411K	0.11%	357
2016 Q3	–	Sell	-20,100	Closed	-$479K	–	560
2016 Q2	$479K	Buy	20,100 +100	+0.5%	+$2.4K	0.23%	140
2016 Q1	$475K	Buy	+20,000	New	+$489K	0.32%	94

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fox Run Management's GMED Position: Q2 2026 in Review

Fox Run Management increased its Globus Medical (GMED) stake by 51% in Q2 2026, buying an estimated $110K and bringing the position to 3,842 shares worth $304K. The position accounts for 0.05% of the portfolio, ranked #669.

Fox Run Management first reported a position in GMED in Q1 2016 and has held it in 12 quarters since. The position peaked at $1.07M in Q1 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Fox Run Management held 3,842 shares of Globus Medical worth $304K as of Q2 2026.
Fox Run Management bought 1,294 Globus Medical shares in Q2 2026, an estimated $110K.
Globus Medical made up 0.05% of Fox Run Management's portfolio in Q2 2026, its #669 holding.
Fox Run Management first reported a position in Globus Medical in Q1 2016 and has held it in 12 quarters since.
Fox Run Management's Globus Medical position peaked at $1.07M in Q1 2024.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.